Metformin Hydrochloride Tablet, Film Coated, Extended Release
Pricing Report NDC 11788-037-60
Current Package Pricing Information
The current wholesale acquisition cost for Metformin Hydrochloride (NDC 11788-037-60) is $0.16440 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.
As a a human prescription drug provided by Aiping Pharmaceutical, Inc., this medication is distributed in a 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $0.16440 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Aug 2026, the NADAC wholesale price for (NDC ) has moved within a range of $0.13832 to $0.16440 per EA. Over this the last few weeks period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$0.1383 - $0.1644
18.85% Variance
18.85%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Sep 23, 2026 | $0.16440 | EA | C/I - Chain or Independent Pharmacy | Code 1 | G - Generic |
| Aug 26, 2026 | $0.13832 | EA | C/I - Chain or Independent Pharmacy | Code 1 | G - Generic |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: October 07, 2026
